BG Medicine Reports Third Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- S&P 500, Nasdaq reach record closing highs as focus pivots to earnings
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
- HubSpot to cut 7% of workforce in restructuring plan
- Paramount Skydance to close WBD deal, change ticker to SKYD
- Citi cuts investment banking analyst program to two years - Bloomberg
- Emera and Canadian Utilities agree to merge in $72B all-share deal
- Nasdaq notches record high close as investors focus on earnings
BG Medicine (BGMD) Reports Q3 Loss of $0.27/Share
November 17, 2015 7:52 AM ESTBG Medicine (: BGMD) reported Q3 EPS of ($0.27), versus ($0.28) reported last year. Revenue for the quarter came in at $334 million, versus $695 million reported last year.
Our operating results in the third quarter of 2015 reflect our ongoing efforts to extend our cash runway through the... More



